Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension Recruiting Phase 4 Trials for Amlodipine (DB00381)

IndicationStatusPhase
DBCOND0083396 (Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02996916Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose TissueTreatment